Italia markets open in 5 hours 44 minutes
Dow Jones
39.872,99 +66,22 (+0,17%) Nasdaq
16.832,62 +37,75 (+0,22%) Nikkei 225
38.667,76 -279,17 (-0,72%) EUR/USD
1,0861 +0,0002 (+0,02%) Bitcoin EUR
64.623,71 -859,62 (-1,31%) CMC Crypto 200
1.524,32 +35,78 (+2,40%)
NVCR May 2024 12.500 call
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
In data: 11:32AM EDT. Mercato aperto.
| Chiusura precedente | 8,80 |
| Aperto | 8,80 |
| Denaro | 9,10 |
| Domanda | 11,70 |
| Prezzo d'esercizio | 12,50 |
| Scadenza | 2024-05-17 |
| Min-Max giorno | 8,80 - 8,80 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 1,79k |
GlobeNewswireZai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in
© 2024 Yahoo. Tutti i diritti riservati.